233 related articles for article (PubMed ID: 18756649)
1. Safety of kava for patients with mild anxiety disorders.
Saeed SA; Bloch RM; Antonacci DJ
Am Fam Physician; 2008 Aug; 78(4):433-4. PubMed ID: 18756649
[No Abstract] [Full Text] [Related]
2. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
Sarris J; LaPorte E; Schweitzer I
Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
[TBL] [Abstract][Full Text] [Related]
3. Kava update: a European perspective.
Ernst E
N Z Med J; 2004 Nov; 117(1205):U1143. PubMed ID: 15570327
[No Abstract] [Full Text] [Related]
4. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
5. Kava (Piper methysticum).
J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
[No Abstract] [Full Text] [Related]
6. Herb-drug interactions: interactions between kava and prescription medications.
Bressler R
Geriatrics; 2005 Sep; 60(9):24-5. PubMed ID: 16153141
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
Witte S; Loew D; Gaus W
Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
9. Kava.
Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
[No Abstract] [Full Text] [Related]
10. Anesthetic considerations of the herbal, kava.
Raduege KM; Kleshinski JF; Ryckman JV; Tetzlaff JE
J Clin Anesth; 2004 Jun; 16(4):305-11. PubMed ID: 15261327
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity reaction to kava-kava extract.
Schmidt P; Boehncke WH
Contact Dermatitis; 2000 Jun; 42(6):363-4. PubMed ID: 10871112
[No Abstract] [Full Text] [Related]
12. Therapeutic potential of kava in the treatment of anxiety disorders.
Singh YN; Singh NN
CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
[TBL] [Abstract][Full Text] [Related]
13. Is kava extract effective for treating anxiety?
Abadi S; Papoushek C; Evans MF
Can Fam Physician; 2001 Sep; 47():1745-7. PubMed ID: 11570299
[No Abstract] [Full Text] [Related]
14. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
15. Herb-drug interactions.
Cranwell-Bruce L
Medsurg Nurs; 2008 Feb; 17(1):52-4. PubMed ID: 18429542
[No Abstract] [Full Text] [Related]
16. Kava Hepatotoxicity: Are we any closer to the truth?
Anke J; Ramzan I
Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
[TBL] [Abstract][Full Text] [Related]
17. Back to basics.
Rubin D; McGovern B; Kopelman RI
Am J Med; 2006 Jun; 119(6):482-3. PubMed ID: 16750959
[No Abstract] [Full Text] [Related]
18. What are the uses and dangers of kava?
Hirsch M
Harv Ment Health Lett; 2000 Nov; 17(5):8. PubMed ID: 11063543
[No Abstract] [Full Text] [Related]
19. A systematic review of the safety of kava extract in the treatment of anxiety.
Stevinson C; Huntley A; Ernst E
Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
[TBL] [Abstract][Full Text] [Related]
20. Relevant hepatotoxic effects of kava still need to be proven. A statement of the Society for Medicinal Plant Research.
Society for Medicinal Plant Research
Planta Med; 2003 Nov; 69(11):971-2. PubMed ID: 14735431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
